Rare diseases
Investigational molecules
Locations
Ul. Terebelska 57/65, 21-500 Biala Podlaska, Poland
Wojewodzki Szpital Specjalistyczny W Bialej Podlaskiej in Biala Podlaska, Poland specialises in clinical trials of conditions such as Breast cancer, Chronic lymphocytic leukaemia, Acute myeloid leukaemia, B-cell small lymphocytic lymphoma, and other specialisations. This site conducts important research.
The center is at the forefront of hematologic oncology, focusing on innovative treatments for aggressive B-cell non-Hodgkin lymphoma and chronic lymphocytic leukemia. Research includes evaluating novel combinations and monotherapies to enhance anti-lymphoma activity and improve patient outcomes.
These studies aim to refine therapeutic strategies, offering hope for patients with limited treatment options.
Specializing in renal cell carcinoma, the center conducts pivotal trials comparing the efficacy of various drug combinations. These studies aim to improve progression-free survival and overall response rates in patients with advanced or metastatic conditions.
By exploring novel therapeutic combinations, the center seeks to enhance treatment efficacy and patient quality of life.
The center is advancing research in myeloproliferative neoplasms, particularly focusing on myelofibrosis. Investigations include evaluating the efficacy of new drug combinations to manage symptoms and improve patient outcomes.
These efforts aim to provide more effective treatment options for patients with this challenging condition.
In the realm of oncology supportive care, the center is exploring treatments for chemotherapy-induced thrombocytopenia and cancer cachexia. These studies focus on improving the quality of life and treatment adherence for cancer patients.
Research in this area aims to mitigate the side effects of cancer treatments, enhancing patient well-being.
More sites in Biala PodlaskaPoland
Clinical trials currently enrolling participants at this site.
PolandStudy on Long-term Safety of Nivolumab and Drug Combination for Cancer Patients from Previous BMS Trials
PolandStudy of ziftomenib with drug combinations for adults with newly diagnosed acute myeloid leukemia with NPM1 or KMT2A genetic changes
PolandStudy of Izalontamab Brengitecan Compared to Standard Chemotherapy in Untreated Triple-negative or ER-low, HER2-negative Breast Cancer Patients Not Eligible for Anti-PD1/PD-L1 Treatment
PolandStudy on CDR132L for Heart Failure with Reduced Ejection Fraction and Left Ventricular Hypertrophy in Adults
PolandStudy Comparing Amivantamab and Drug Combination for Patients with Recurrent or Metastatic Colorectal Cancer Without KRAS/NRAS and BRAF Mutations
PolandStudy of Lisaftoclax Alone or with Drug Combination for Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
PolandStudy on the Effectiveness and Safety of Saruparib and Camizestrant in Adults with Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer
PolandStudy on Zanidatamab and Chemotherapy for Patients with Metastatic HER2-Positive Breast Cancer After Trastuzumab Deruxtecan Treatment
PolandStudy Comparing Pirtobrutinib and Ibrutinib for Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
PolandStudy on Balcinrenone and Dapagliflozin for Patients with Heart Failure and Kidney Problems
PolandStudy on THIO and Cemiplimab for Patients with Advanced Non-Small Cell Lung Cancer
PolandMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
